Reduced α‐synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Reduced α‐synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity

Authors:	K. D. van Dijk M. Bidinosti A. Weiss P. Raijmakers H. W. Berendse W. D. J. van de Berg

Affiliation:	1. Department of Anatomy and Neurosciences, Section of Functional Neuroanatomy, Neuroscience Campus Amsterdam, VU University Medical Center, , Amsterdam, The Netherlands;2. Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, , Amsterdam, The Netherlands;3. Novartis Institutes for Biomedical Research, Novartis Pharma AG, , Basel, Switzerland;4. IRBM Promidis, , Pomezia, Italy;5. Department of Nuclear Medicine & PET Research, VU University Medical Center, , Amsterdam, The Netherlands

Abstract:

Keywords:	biomarker cerebrospinal fluid DAT‐SPECT Parkinson's disease α ‐synuclein